Florida Medicaid

Does Florida Medicaid cover Mounjaro?

Find your Medicaid card name in Florida

Quick answer · Type 2 Diabetes

Florida Medicaid covers Mounjaro for type 2 diabetes with prior authorization on Medicaid.

  • Medicaid: Covered (preferred drug). A1C of 6.5% or higher

Last verified June 4, 2026. Policy effective June 16, 2025. Source: Glucagon-like%20Peptide-1%20(GLP-1)%20Receptor%20Agonist%20and%20Related%20Agents%2003.12.2026.pdf. How we verify this data →

Check your card for your exact plan →

Mounjaro for Type 2 Diabetes

What Florida Medicaid requires, by plan type. Open this indication on its own page →

Medicaid

Covered (preferred drug)

What you need to qualify

  • Age 10 and older
  • A1C of 6.5% or higher
  • Trial of metformin for at least 90 days, or a documented reason it can't be used (["intolerance", "contraindication"])
  • Lab results confirming eligibility

Qualification pathways

You can qualify through any one of these.

Initial approval for Type 2 Diabetes (Preferred Agent)

All of:

  • Patient is >= 10 years of age
  • Diagnosis of type 2 diabetes mellitus
  • HbA1c >= 6.5% measured within the past 6 months (documentation required)
  • Trial and failure of metformin within the past 2 years, unless contraindicated or patient is intolerant (documentation required)

Documentation to bring

  • HbA1c lab result >= 6.5% within the past 6 months
  • Documentation of metformin trial and failure within the past 2 years, OR documentation of contraindication or intolerance to metformin

Approval and renewal

  • Initial approval: 12 months
  • Renewal: every 12 months
  • To renew, the plan looks for improvement in A1C and Documentation of improved clinical response (e.g., decline in HbA1c); patient has not experienced any treatment-restricting adverse effects; dosing is appropriate per labeling or supported by compendia. Initial BMI, metformin trial, and preferred agent step therapy are not re-verified at continuation.

Policy note: Mounjaro is listed as a preferred agent requiring Clinical Prior Authorization. Minimum age is 10 years (lower than Ozempic's 18 years), consistent with FDA-approved labeling for Mounjaro in pediatric patients with T2DM. The metformin trial lookback window is 2 years. A1C lookback window is 6 months. The document also covers Wegovy and Zepbound only for weight management/OSA indications, which are not addressed in this document; therefore no entries are emitted for those brands or indications. Trulicity (dulaglutide) is a preferred agent per this document but is not in the in-scope brand list, so no criteria entry is emitted. Rybelsus (oral semaglutide) and Victoza (liraglutide) are listed as non-preferred agents but are not in the in-scope brand list for separate entries.

Policy effective June 16, 2025 · verified June 4, 2026 · source: Glucagon-like%20Peptide-1%20(GLP-1)%20Receptor%20Agonist%20and%20Related%20Agents%2003.12.2026.pdf

Why Mounjaro requests get denied by Florida Medicaid

Based on what this policy asks for. Fix these before the first submission.

  1. Wrong brand for the diagnosis. Mounjaro and Zepbound are the same molecule with different approved uses; a request for Mounjaro under a diagnosis that matches Zepbound is routinely denied.
  2. No recent A1C result on file.
  3. No documented metformin trial (dose, dates, and outcome) or a stated reason it can't be used.

Frequently asked questions

Does Florida Medicaid cover Mounjaro?
Florida Medicaid covers Mounjaro for type 2 diabetes with prior authorization on Medicaid.
Do you have to try metformin before Mounjaro?
Yes for type 2 diabetes: Florida Medicaid requires a documented trial of metformin of at least 90 days, or a documented reason it can't be used (["intolerance", "contraindication"]).
How long does a Mounjaro approval last with Florida Medicaid?
Initial approvals last 12 months, and renewals are granted in 12-month periods.
What does Florida Medicaid require to renew Mounjaro?
Improvement in A1C and Documentation of improved clinical response (e.g., decline in HbA1c); patient has not experienced any treatment-restricting adverse effects; dosing is appropriate per labeling or supported by compendia. Initial BMI, metformin trial, and preferred agent step therapy are not re-verified at continuation.
How current is this information?
This page reflects Florida Medicaid's written policy as of June 16, 2025, last verified against the source document on June 4, 2026.

Other medications under Florida Medicaid

Mounjaro coverage under other plans

All insurance plans · All medications

This page summarizes Florida Medicaid's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.